The results do not support use of oral iron supplementation in patients with HFrEF and iron deficiency, and high-dose oral iron did not improve exercise capacity over 16 weeks.
Iron
Cognition, memory, and focus is the main area connected here, and any felt benefit should be read together with the human evidence base.
Representative tier calculated from paper evidence that passed the collection audit.
Main benefit evidence
The representative ingredient tier is calculated from these target-level evidence groups.
Cognition and focus2 studiesTier-BCognition, memory, and focusFairly consistent positive signal in studiesFelt benefit focusSupplement contextPotential benefit studied in Cognition and focus.Open metrics>
Nutrient status4 studiesTier-CNutrient status markersFairly consistent positive signal in studiesResearch marker focusSupplement contextThis card is closer to a measured biomarker or lab outcome than a directly felt user benefit.Closer to a research marker than a directly felt benefit.Open metrics>
Condition-specific evidence2 studiesTier-CCondition-specific health context in a specific contextFairly consistent positive signal in studiesResearch marker focusSupplement contextThis result was studied for Condition-specific health context in a narrower population or condition-specific context. It should not be generalized as an everyday supplement effect.Closer to a research marker than a directly felt benefit.Open metrics>
Blood pressure and vascular health1 studiesTier-CBlood pressure and vascular health markersSome positive signal observedResearch marker focusPatient-group studyThis card is closer to a measured biomarker or lab outcome than a directly felt user benefit.Closer to a research marker than a directly felt benefit.Open metrics>
Women's health1 studiesTier-CMenstrual and women's healthSome positive signal observedFelt benefit focusPatient-group studyPotential benefit studied in Women's health.Open metrics>
Blood lipids1 studiesTier-CCholesterol and triglyceridesSome positive signal observedFelt benefit focusPatient-group studyPotential benefit studied in Blood lipids.Open metrics>
Recent research
10 new papers were added in this period. No new risk signal was identified.
What's new
Most notable recent finding
Study dosage range (reference only)
Key cautions to review
Standalone side-effect signals and combination cautions are listed separately.
Standalone side effects
Evidence summaries
Paper IDs and full lists are private. Only study types and summaries are shown.
Deferiprone therapy was well tolerated and was associated with a reduced dentate and caudate nucleus iron content compared to placebo, which supports more extensive clinical trials into the potential benefits of iron chelation in PD.
Prophylactic antenatal oral iron supplements when given intermittently were not effective in preventing iron deficiency anaemia in pregnancy.
3 more summariesLimited representative sample by study type.>
Among blood donors with normal hemoglobin levels, low-dose iron supplementation, compared with no supplementation, reduced time to 80% recovery of the postdonation decrease in hemoglobin concentration in donors with low ferritin (≤26 ng/mL) or higher ferritin
This review considers the physiology of iron as a nutrient and how this physiology informs decision-making about weighing the benefits and risks of iron supplementation in iron-deficient, iron-sufficient, and iron-overloaded pregnant women and children.
In patients with METS, phlebotomy, with consecutive reduction of body iron stores, lowered BP and resulted in improvements in markers of cardiovascular risk and glycemic control.